Refractory gastroesophageal reflux disease: advances and treatment
- PMID: 24745809
- DOI: 10.1586/17474124.2014.910454
Refractory gastroesophageal reflux disease: advances and treatment
Abstract
'Refractory gastroesophageal reflux disease' is one of the most common misnomers in the area of gastroesophageal reflux disease. The term implies reflux as the underlying etiology despite unresponsiveness to aggressive proton pump inhibitor therapy. The term should be replaced with 'refractory symptoms.' We must acknowledge that in many patients symptoms of reflux often overlap with non-GERD causes such as gastroparesis, dyspepsia, hypersensitive esophagus and functional disorders. Lack of response to aggressive acid suppressive therapy often leads to diagnostic testing. In majority of patients these tests are normal. The role of non-acid reflux in this group is uncertain and patients should not undergo surgical fundoplication based on this parameter. In patients unresponsive to acid suppressive therapy GERD is most commonly not causal and a search for non-GERD causes must ensue.
Keywords: achalasia; acid suppressive therapy; functional upper gut symptoms; gastroparesis; refractory symptoms.
Similar articles
-
New Approaches to Management of PPI-Refractory Gastroesophageal Reflux Disease.Curr Treat Options Gastroenterol. 2014 Mar;12(1):18-33. doi: 10.1007/s11938-013-0002-7. Curr Treat Options Gastroenterol. 2014. PMID: 24430334
-
Patients with refractory reflux symptoms often do not have GERD.Neurogastroenterol Motil. 2015 Sep;27(9):1267-73. doi: 10.1111/nmo.12620. Epub 2015 Jun 18. Neurogastroenterol Motil. 2015. PMID: 26088946
-
ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?Arq Gastroenterol. 2018 Nov;55Suppl 1(Suppl 1):85-91. doi: 10.1590/S0004-2803.201800000-48. Epub 2018 Oct 4. Arq Gastroenterol. 2018. PMID: 30304291 Review.
-
Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group.Dis Esophagus. 2013 Nov-Dec;26(8):755-65. doi: 10.1111/j.1442-2050.2012.01384.x. Epub 2012 Aug 7. Dis Esophagus. 2013. PMID: 22882487 Review.
-
Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?Am J Gastroenterol. 2008 Oct;103(10):2446-53. doi: 10.1111/j.1572-0241.2008.02033.x. Epub 2008 Aug 5. Am J Gastroenterol. 2008. PMID: 18684197 Clinical Trial.
Cited by
-
Assessment of the Multiple Rapid Swallows Test for Gauging Esophageal Reflux Burden in Patients with Refractory Gastroesophageal Reflux Disease.Med Sci Monit. 2021 Feb 19;27:e928554. doi: 10.12659/MSM.928554. Med Sci Monit. 2021. PMID: 33602889 Free PMC article.
-
Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy.Singapore Med J. 2016 Oct;57(10):546-551. doi: 10.11622/smedj.2016167. Singapore Med J. 2016. PMID: 27779277 Free PMC article.
-
The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring.Med Sci Monit. 2020 Nov 21;26:e927381. doi: 10.12659/MSM.927381. Med Sci Monit. 2020. PMID: 33220027 Free PMC article.
-
A stepwise protocol for the treatment of refractory gastroesophageal reflux-induced chronic cough.J Thorac Dis. 2016 Jan;8(1):178-85. doi: 10.3978/j.issn.2072-1439.2016.01.50. J Thorac Dis. 2016. PMID: 26904227 Free PMC article.
-
Refractory Gastroesophageal Reflux Disease: A Management Update.Front Med (Lausanne). 2021 Nov 1;8:765061. doi: 10.3389/fmed.2021.765061. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34790683 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical